{"id":232074,"date":"2017-08-03T07:48:55","date_gmt":"2017-08-03T11:48:55","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/omega-healthcare-investors-strong-buy-below-30-seeking-alpha.php"},"modified":"2017-08-03T07:48:55","modified_gmt":"2017-08-03T11:48:55","slug":"omega-healthcare-investors-strong-buy-below-30-seeking-alpha","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/omega-healthcare-investors-strong-buy-below-30-seeking-alpha.php","title":{"rendered":"Omega Healthcare Investors: Strong Buy Below $30 &#8211; Seeking Alpha"},"content":{"rendered":"<p><p>    Omega Healthcare Investors (OHI) shares are already a    bargain, but they could get even cheaper as part of a wider    market drop. With stocks sitting near record highs, a price    drop of five to ten percent is fully within the realm of    possibility, and investors need to plan accordingly. I am    increasing my cash levels now in order to be able to take    advantage of an inevitable market drop that would make quality    income vehicles like Omega Healthcare Investors even cheaper.  <\/p>\n<p>    Can you even remember the last time stock prices dropped 5    percent, 10 percent, or even 20 percent? And can you recall how    painful the last bear market was for most investors? Chances    are you cant because stock prices have been steadily climbing    in the last couple of years, and the 2007 market crash happened    almost a decade ago. In short, investors have short memories,    and they have become way too complacent.  <\/p>\n<p>    Earnings season has been pretty good so far for companies and    investors, and, by extension, stocks. That said, though,    todays complacency paired with investors willingness to buy    into stocks at record levels is a convincing reason to be    fearful. Valuations, on average, are pretty high, and they    coincide with something else: Overbought sentiment.  <\/p>\n<p>    As a matter of fact, I think there are three overriding reasons    why investors should be prepared to buy into Omega Healthcare    Investors as pressure on valuations begins to mount:  <\/p>\n<p>    Omega Healthcare Investors has invested $5.8 billion in the    growth of its real estate portfolio in the last thirteen and a    half years - $1.3 billion in 2016 alone - in order to morph    into a health care REIT with a national presence.  <\/p>\n<\/p>\n<p>    Source: Omega Healthcare Investors  <\/p>\n<p>    Omega Healthcare Investors now has operating facilities in 42    states and in the United Kingdom.  <\/p>\n<\/p>\n<p>    Source: Omega Healthcare Investors  <\/p>\n<p>    Omega Healthcare Investors works closely with health care    facility operators. While the health care REITs relationships    with its operator base have evolved over time, no operator    poses an outsized risk to Omega in terms of revenues.  <\/p>\n<p>     Source: Omega Healthcare Investors  <\/p>\n<p>    In addition to a widely diversified real estate portfolio,    Omega Healthcare Investors has had industry-beating occupancy    rates.  <\/p>\n<p>        Source: Omega Healthcare Investors  <\/p>\n<p>    Omega Healthcare Investors just reported robust Q2-17 results,    and continues to display top-shelf dividend coverage for a    health care REIT. I recently doubled down on Omega Healthcare    Investors as the REIT combines excess dividend coverage with an    above-average commitment to raising its dividend payout every    single quarter (Omega Healthcare Investors just raised its    dividend for the 20th consecutive quarter and the new dividend    rate is $0.64\/share).  <\/p>\n<p>    Omega Healthcare Investors is in a stable financial position    and can continue to grow its dividend. I updated Omega    Healthcare Investors dividend coverage chart for its second    quarter results, and the real estate investment trust should    have no problems growing its dividend payout by $0.01\/share    moving forward.  <\/p>\n<\/p>\n<p>    Source: Achilles Research  <\/p>\n<p>    Omega Healthcare Investors guided for adjusted funds from    operations of $3.42-$3.44\/share for the current year. Based on    this guidance, income investors seeking to access Omega    Healthcare Investors 8.2 percent dividend, pay 9.1x 2017e    AFFO. A market slide would translate into an even lower AFFO    multiple (and higher cash flow yield), increasing investors    margin of safety.  <\/p>\n<p>    Income investors pay a premium to the REIT's book value. The    premium valuation is justified in my opinion based on Omega's    above-average dividend visibility, high cash flow yield, and    potential for AFFO growth.  <\/p>\n<p>    Investors have been piling into stocks for more than eight    years (where do you think all that central bank money went?),    pushing investors into risky assets and inflating their prices.    Against this backdrop, I think the time has come to be a little    more cautious, and raise cash in order to gobble up    high-quality income vehicles when they are on sale.  <\/p>\n<p>    If you have read my articles before you know that I have almost    entirely liquidated my high-yield income portfolio earlier this    year - primarily BDCs and mortgage REITs - due to concerns    about stretched valuations and overbought sentiment, and    because good investment opportunities have become increasingly    hard to find.  <\/p>\n<p>    Considering that a 5-10 percent market drop is entirely within    the realms of possibility, having cash at hand to deploy during    a market drop is the smart thing to do.  <\/p>\n<p>    Omega Healthcare Investors has assembled a high-quality,    geographically-diversified skilled nursing facility portfolio    that throws off a growing stream of FFO. I have doubled down on    the health care REIT because of its low valuation, and because    it has a high degree of dividend coverage\/visibility. Omegas    second quarter results continued to show AFFO resilience and    very good dividend coverage.  <\/p>\n<p>    That said, I think income investors need to raise their cash    levels in order to be able to scoop up high-quality income    vehicles like Omega Healthcare Investors once the market falls    back from its recent highs. Though Omega Healthcare Investors    already makes a solid value proposition, I think the    reward-to-risk ratio looks particularly attractive below $30.  <\/p>\n<p>    If you like to read more of my articles, and like to be    kept up to date with the companies I cover, I kindly ask you    that you scroll to the top of this page and click    'follow'. I am largely    investing in dividend paying stocks, but also venture out    occasionally and cover special situations that offer appealing    reward-to-risk ratios and have potential for significant    capital appreciation. Above all, my immediate investment goal    is to achieve financial independence.  <\/p>\n<p>  Disclosure: I am\/we are long OHI.<\/p>\n<p>  I wrote this article myself,  and it expresses my own opinions. I am not receiving compensation  for it (other than from Seeking Alpha). I have no business  relationship with any company whose stock is mentioned in this  article.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original:<\/p>\n<p><a target=\"_blank\" href=\"https:\/\/seekingalpha.com\/article\/4094124-omega-healthcare-investors-strong-buy-30\" title=\"Omega Healthcare Investors: Strong Buy Below $30 - Seeking Alpha\">Omega Healthcare Investors: Strong Buy Below $30 - Seeking Alpha<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Omega Healthcare Investors (OHI) shares are already a bargain, but they could get even cheaper as part of a wider market drop. With stocks sitting near record highs, a price drop of five to ten percent is fully within the realm of possibility, and investors need to plan accordingly. I am increasing my cash levels now in order to be able to take advantage of an inevitable market drop that would make quality income vehicles like Omega Healthcare Investors even cheaper.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/omega-healthcare-investors-strong-buy-below-30-seeking-alpha.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-232074","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/232074"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=232074"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/232074\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=232074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=232074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=232074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}